Massive Losses for Intercell

Published: March 2, 2011; 00:00 · (Vindobona)

The Austrian pharmaceutical company today reported losses for 2010 amounting to € 255m. Operating cash flow has been strongly negative too.

Massive Losses for Intercell / Picture: © Vindobona.org

Today Intercell AG (VSE: ICLL) announced its financial results for Q4 and the preliminary results for the full financial year 2010 and presented an update on the Company’s development programs.

In 2010, Intercell experienced a serious backdrop in its development. Due to a cancelled program for the development of vaccines, the company had to…

This article includes a total of 1210 words.

or Log In

Fast News Search

Join us to succeed in Vienna! Sign up to read articles for free and to get personalized updates on the events that interest you.

Massive Losses for Intercell

The Austrian pharmaceutical company today reported losses for 2010 amounting to € 255m. Operating cash flow has been strongly negative too.

Join us to succeed in Vienna!
Sign up to read articles for free and to get personalized updates on the events that interest you.